Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Other3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT05710887Phase 2Withdrawn
N2O for Acute Suicidality and Depression in the ED
Major Depressive DisorderSuicidal IdeationTreatment Resistant Depression
PrincipalinvestigatorStart date: 2026-02-27
NCT05357066Phase 2Withdrawn
Nitrous Oxide as Treatment for Fibromyalgia
Central Neuropathic PainFibromyalgia
PrincipalinvestigatorStart date: 2021-11-12
NCT05357040Phase 2Withdrawn
Antidepressant Effects of Nitrous Oxide
Major Depressive DisorderTreatment Resistant Depression
PrincipalinvestigatorStart date: 2021-06-30

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of Chicago, Department of Anesthesia and Critical Care

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Paul Myles, MD

The Alfred Hospital, Department of Anesthesiology and Perioperative Medicine

Related
1 trials

Shared therapeutic areas:

Major Depressive DisorderDepressive Disorder, Treatment-Resistant

Worked with same sponsors:

The AlfredUniversity of Chicago
Collaborated on 1 trial
Similarity Score24%

Mark George, MD

Medical University of South Carolina

Related
6 trials

Shared therapeutic areas:

Major Depressive DisorderDepressive Disorder, Treatment-Resistant
Similarity Score12%

Charles Conway, MD

Washington University School of Medicine

Related
6 trials

Shared therapeutic areas:

Depressive Disorder, Treatment-ResistantMajor Depressive Disorder
Similarity Score12%

Carlos A Zarate, M.D.

National Institute of Mental Health (NIMH)

Related
19 trials

Shared therapeutic areas:

Major Depressive DisorderDepressive Disorder, Treatment-Resistant
Similarity Score12%

Project Leader

Ono Pharmaceutical Co., Ltd.

Related
47 trials

Shared therapeutic areas:

FibromyalgiaMajor Depressive Disorder
Similarity Score12%

Hesheng Liu, Ph.D.

Changping Laboratory

Related
20 trials

Shared therapeutic areas:

Major Depressive DisorderDepressive Disorder, Treatment-Resistant
Similarity Score12%

Leighton Y. Huey, MD

UConn Health

Related
1 trials

Shared therapeutic areas:

Major Depressive Disorder
Similarity Score6%

Azfar Malik, MD

Psych Care Consultants Research

Related
1 trials

Shared therapeutic areas:

Major Depressive Disorder
Similarity Score6%

Thomas Schwartz, MD

SUNY UMU at Syracuse

Related
1 trials

Shared therapeutic areas:

Major Depressive Disorder
Similarity Score6%

Craig J Vine, MD

Psychiatric Recovery

Related
1 trials

Shared therapeutic areas:

Major Depressive Disorder
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05710887Phase 2PrincipalInvestigator

N2O for Acute Suicidality and Depression in the ED

Major Depressive DisorderSuicidal IdeationTreatment Resistant Depression
Withdrawn
NCT05357066Phase 2PrincipalInvestigator

Nitrous Oxide as Treatment for Fibromyalgia

Central Neuropathic PainFibromyalgia
Withdrawn
NCT05357040Phase 2PrincipalInvestigator

Antidepressant Effects of Nitrous Oxide

Major Depressive DisorderTreatment Resistant Depression
Withdrawn

All 3 trials loaded